Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/Net Sales

    Back to All Ratios
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Net Sales(x) 2.812.5423.320.904.92

What is the latest EV/Net Sales ratio of ORCHID PHARMA ?

The latest EV/Net Sales ratio of ORCHID PHARMA is 2.81 based on Mar2023 Consolidated results.
Year EV/Net Sales
Mar20232.81
Mar20222.54
Mar202123.32
Mar20200.90
Mar20194.92

How is EV/Net Sales of ORCHID PHARMA Trending?

Years EV/Net Sales % Change
Mar2023 2.81
10.63
Mar2022 2.54
-89.11
Mar2021 23.32
2,491.11
Mar2020 0.9
-81.71
Mar2019 4.92 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/Net Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹5,508.3 Cr 2.6% 1.9% 175% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,167.0 Cr 2.6% -4.7% 54.7% Stock Analytics
CIPLA ₹113,645.0 Cr 4.4% -4.4% 54.7% Stock Analytics
DIVIS LABORATORIES ₹105,890.0 Cr 5.8% 17.7% 24.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,987.0 Cr 5.7% 2.7% 29.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,950.6 Cr 0.4% -5.4% 82.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

2.6%

1.9%

175%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses